VISCHER AG has advised Oculis. Oculis Holding AG has entered into an asset purchase agreement with Accure Therapeutics, S.L., to acquire all worldwide development and commercial...
Oculis Acquires Global Rights to Privosegtor and ACT-02 from Accure Therapeutics
Memo Therapeutics AG Sold to Ipsen in Transaction Centered on BK Polyomavirus Antibody
VISCHER AG and Baker McKenzie have advised Memo Therapeutics AG and its shareholders. Lenz & Staehelin, together with Bredin Prat, have represented Ipsen. Memo Therapeutics AG,...
Eli Lilly Acquires LimmaTech Biologics for Up to USD 780 Million
Homburger has advised Eli Lilly. LimmaTech is supported by Moelis & Company UK LLP as financial advisor and Goodwin Procter and VISCHER as legal advisors. On...
AstraZeneca Acquires Swiss Biotech Firm SixPeaks Bio in USD 300 Million Deal
Walder Wyss has advised SixPeaks Bio AG and its shareholders (including Versant Ventures). Lenz & Staehelin has advised AstraZeneca. AstraZeneca has completed the acquisition of Swiss...
Mosanna Therapeutics Completes USD 80 Million Series A Funding Round
VISCHER has advised Mosanna Therapeutics AG; Walder Wyss advised EQT Life Sciences. Mosanna Therapeutics AG has successfully closed its USD 80 million Series A funding round....
SixPeaks Bio AG’s $110 Million Series A Financing Round
Walder Wyss advised SixPeaks Bio AG while Lenz & Staehelin acted as Swiss counsel to AstraZeneca. SixPeaks Bio AG has secured USD30 million in Series A...
Axalta Coating Systems Group’s Acquisition of Andre Koch AG
Walder Wyss advised Axalta Coating Systems on this transaction. Axalta Coating Systems Group (NYSE: AXTA) acquired André Koch AG, an established provider of car repair and...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
CONVOTIS GmbH’s Acquisition of Acdalis AG
Walder Wyss advised CONVOTIS on all aspects of Swiss law on the transaction. CONVOTIS strengthens its position in Switzerland with the acquisition of acdalis AG, a...
Pierre Fabre Laboratories’ Acquisition of Vertical Bio AG
Walder Wyss advised Versant Ventures on this transaction. ierre Fabre Laboratories, the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer...
GEODIS’ Acquisition of ITS – International Transport & Shipping Ltd.
Walder Wyss advised the ITS shareholders in this transaction. GEODIS, one of the world’s leading transport and logistics companies, has acquired Swiss freight forwarder ITS –...